Table 2*

Coverage of modelled interventions at baseline and endline by scenario (weighted by total population)*

Category	Intervention	Baseline in 2016 (%)	Endline in 2030 (%)
Category	Intervention	Baseline in 2016 (%)	Historic trends	GFF Conservative	GFF Ambitious	Best case
Antenatal period	Balanced energy supplementation	0	–	0	30	90
	Diabetes case management	21	38	70	70	90
	Hypertensive disorder case management	49	61	71	71	90
	Intermittent preventive treatment of malaria during pregnancy	41	94	94	94	94
	MgSO₄ management of pre-eclampsia	32	50	70	70	90
	Multiple micronutrient supplementation in pregnancy	0	–	82	82	90
	Syphilis detection and treatment	19	25	70	70	90
	Tetanus toxoid vaccination	86	91	91	91	91
Childbirth period	Induction of labour for pregnancies lasting 41+weeks (tertiary care)	33	47	81	81	90
	Interventions associated with health facility delivery: antibiotics for pPRoM, MgSO₄ management of eclampsia, active management of the third stage of labour	42	78	81	81	90
	Interventions associated with skilled birth attendance: clean birth practices, labour and delivery management, immediate assessment and stimulation of neonate	67	82	85	85	90
	Neonatal resuscitation (facility-based)	59	78	81	81	90
Postnatal period	Breastfeeding promotion	45	45	70	70	90
Immunisation *Projected trends from Gavi	Measles vaccine*	81	89	89	89	90
	Meningococcal vaccine	0	–	70	70	90
	Pentavalent vaccine* (diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b)	82	85	85	85	90
	Pneumococcal vaccine*	32	84	84	84	90
	Rotavirus vaccine*	16	84	84	84	90
Preventive services	Chlorhexidine	0	–	70	70	90
	Clean postnatal practices	34	51	76	76	90
	Hand washing with soap	57	55	72	72	90
	ITN/IRS: households protected from malaria	27	49	82	82	90
	Infant and young child feeding promotion:education only about appropriate complementary feeding	25	21	70	70	90
	Supplemental food and education for children ages 6–23 months from food-insecure households	25	21	25	55	55
	Vitamin A supplementation	79	92	93	93	93
Curative	Antibiotics for treatment of dysentery	18	23	70	70	90
	Case management of neonatal prematurity including kangaroo mother care	0	–	70	70	90
	Case management of neonatal sepsis/pneumonia with injectable antibiotics	0	78	81	81	90
	Maternal sepsis case management	0	–	70	70	90
	Oral antibiotics for pneumonia	62	67	74	74	90
	Oral rehydration solution	42	53	71	71	90
	Treatment for severe acute malnutrition with food supplementation	3	13	3	34	34
	Treatment of malaria with artemisinin compounds	5	23	73	73	90
	Vitamin A for treatment of measles	79	92	93	93	93
	Zinc for treatment of diarrhoea	14	18	70	70	90
HIV/AIDS interventions (eg, Prevention of mother-to-child transmission (PMTCT), cotrimoxazole, antiretroviral therapy (ART))			Projected trends from UNAIDS Reference Group on Estimates, Models and Projections (UNAIDS)
Family planning			Projected trends from UN Population Division 2017 Revision of World Population Prospects		Projected trends from UN Population Division 2017 Revision of World Population Prospects OR 75% of current demand satisfied with modern methods by 2030

Intervention coverage follows a pattern of historic change if this projected coverage in 2030 is greater than the preset or designated target (eg, 70%). Interventions with current baseline coverage exceeding the target were held constant through 2030.
IRS, Indoor residual spraying; ITN, Insecticide-treated bednet .